½ÃÀ庸°í¼­
»óǰÄÚµå
1563137

¼¼°èÀÇ ÀǾàǰ ºÎÇüÁ¦ ½ÃÀå(-2029³â)

Excipients in Pharmaceuticals: Global Markets to 2029

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: BCC Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 105 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ÀǾàǰ ºÎÇüÁ¦ ½ÃÀå ±Ô¸ð´Â 2023³â 92¾ï ´Þ·¯, 2024³â 97¾ï ´Þ·¯¿¡¼­ ¿¹Ãø ±â°£ µ¿¾È ¿¬Æò±Õ 5.1% ¼ºÀåÇÏ¿© 2029³â ¸»¿¡´Â 124¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

À¯±â ºÎÇüÁ¦ ºÎ¹®Àº 2024³â 87¾ï ´Þ·¯¿¡¼­ 5.2%ÀÇ CAGR·Î 2029³â ¸»¿¡´Â 112¾ï ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹«±â ÀǾàǰ ºÎÇüÁ¦ ºÎ¹®Àº 2024³â 7¾ï 1,630¸¸ ´Þ·¯¿¡¼­ 2029³â ¸» 8¾ï 6,170¸¸ ´Þ·¯·Î 3.8%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°è ÀǾàǰ ºÎÇüÁ¦ ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä, ½ÃÀå ¿µÇâ¿äÀÎ ¹× ½ÃÀå ±âȸ ºÐ¼®, ±ÔÁ¦ ȯ°æ, ½ÅÈï ±â¼ú ¹× ±â¼ú°³¹ß µ¿Çâ, ½ÃÀå ±Ô¸ð ÃßÁ¤ ¹× ¿¹Ãø, °¢Á¾ ºÎ¹®º°¡¤Áö¿ªº° »ó¼¼ ºÐ¼®, °æÀï ±¸µµ, ÁÖ¿ä ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå °³¿ä

  • ÀǾàǰÀÇ Ã·°¡Á¦ÀÇ ¿ªÇÒ
  • ºÎÇüÁ¦ ±â´É

Á¦3Àå ½ÃÀå ¿ªÇÐ

  • ½ÃÀå ¿ªÇÐ ÇöȲ
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ÀǾàǰ ¹× ¹ÙÀÌ¿ÀÀǾàǰ ¼Òºñ·® Áõ°¡
  • ±â´É¼º ÷°¡Á¦ ¼ö¿ä Áõ°¡
  • ½Å±Ô ÷°¡Á¦ ¼ö¿ä Áõ°¡
  • ºÎÇüÁ¦ Áï½Ã Á¶´Þ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ³ôÀº °³¹ßºñ
  • ½Å±Ô ÷°¡Á¦¿¡ °üÇÑ µ¶¸³ÇÑ ±ÔÁ¦±â°üÀÇ °á¿©
  • ¾ö°ÝÇÑ ÀǾàǰ ±ÔÁ¦
  • ½ÃÀå ±âȸ
  • ¹ÙÀÌ¿ÀÀǾàǰ, ¹ÙÀÌ¿À½Ã¹Ð·¯, Ư¼ö ÀǾàǰ ¼ö¿ä Áõ°¡
  • ½ÃÀå °úÁ¦
  • °ø±Þ¸Á È¥¶õ

Á¦4Àå ½Å±â¼ú°ú °³¹ß

  • °³¿ä
  • ÀǾàǰ Á¦Á¦ÀÇ 3D ÇÁ¸°Æ®
  • ÷°¡Á¦ ¼±ÅÃÀÇ AI
  • »õ·Î¿î ºÎÇüÁ¦
  • ÀÓ»ó½ÃÇè
  • ÁÖ¿ä ÀÓ»ó½ÃÇè

Á¦5Àå ¼¼°èÀÇ ÀǾàǰ ÷°¡Á¦ ½ÃÀå

  • ¼¼ºÐÈ­ ³»¿ª
  • ½ÃÀå ³»¿ª : Àç·á À¯Çüº°
  • À¯±â ÷°¡Á¦ : À¯Çüº°
  • ¹«±â ÷°¡Á¦ : À¯Çüº°
  • USP ¿öÅÍ : À¯Çüº°
  • ½ÃÀå ³»¿ª : Á¦Çüº°
  • ½ÃÀå ³»¿ª : Åõ¿© °æ·Îº°
  • ½ÃÀå ³»¿ª : ÃÖÁ¾»ç¿ëÀÚº°
  • Áö¿ªÀû ³»¿ª
  • ½ÃÀå ³»¿ª : Áö¿ªº°
  • ºÏ¹Ì
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • ±âŸ Áö¿ª
  • ½ÃÀå ³»¿ª : Á¦Ç°º°
  • À¯±â ÷°¡Á¦ : Áö¿ª¡¤±¹°¡º° ½ÃÀå
  • ¹«±â ÷°¡Á¦ : Áö¿ª¡¤±¹°¡º° ½ÃÀå

Á¦6Àå °æÀï Á¤º¸

  • ¾÷°è ½Ã³ª¸®¿À
  • ±â¾÷ Á¡À¯À²
  • °æÀï »óȲ

Á¦7Àå ÀǾàǰ ÷°¡Á¦ ½ÃÀåÀÇ Áö¼Ó°¡´É¼º : ESG °üÁ¡

  • ESG : ¼Ò°³
  • ȯ°æ ÆÛÆ÷¸Õ½º
  • »çȸÀû ÆÛÆ÷¸Õ½º
  • °Å¹ö³Í½º ÆÛÆ÷¸Õ½º
  • BCC¿¡ ÀÇÇÑ °á·Ð

Á¦8Àå ºÎ·Ï

  • Á¶»ç ¹æ¹ý
  • ¾à¾î
  • Âü°í¹®Çå
  • ±â¾÷ °³¿ä
  • ADM
  • ASAHI KASEI CORP.
  • ASHLAND
  • BASF SE
  • CRODA INTERNATIONAL PLC
  • EVONIK INDUSTRIES AG
  • INGREDION
  • KERRY GROUP PLC
  • ROQUETTE FRERES
ksm 24.10.08

The global market for pharmaceutical excipients was valued at $9.2 billion in 2023. It is expected to grow from $9.7 billion in 2024 to $12.4 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.1% from 2024 to 2029.

The global market for organic excipients is expected to grow from $8.7 billion in 2024 to $11.2 billion by the end of 2029, at a CAGR of 5.2% from 2024 to 2029.

The global market for inorganic pharmaceutical excipients is expected to grow from $716.3 million in 2024 to $861.7 million by the end of 2029, at a CAGR of 3.8% from 2024 to 2029.

Report Scope

This report provides a comprehensive summary of pharmaceutical excipients, along with a discussion of the competitive landscape and profiles of key market players that highlight revenues, product portfolios, and recent activities. The report analyzes trends and dynamics, including drivers, limitations, challenges and opportunities. This research study discusses historical, current and potential market size. The report will enable market players and new entrants to make informed decisions about the production and licensing of goods and services. Organizations, distributors and exporters will find useful information about market developments and trends. The report segments the market by three product types: organic, inorganic or water that meets the standards of the U.S. Pharmacopeia (USP). Regional and country-level market analysis is provided for all the major segments. The market excludes the excipients used in the cosmetics, food and beverage, and chemical industries.

The market is divided into segments as follows:

By excipient material type:

  • Organic.
  • Inorganic.
  • USP water.

By organic type:

  • Carbohydrates.
  • Petrochemicals.
  • Oleochemicals.
  • Proteins.
  • Other organic excipients.

By inorganic type:

  • Calcium salts.
  • Halites.
  • Metal oxides.
  • Silicates.
  • Other inorganic excipients.

By dosage form:

  • Solid dosage form.
  • Liquid dosage form.
  • Semisolid dosage form.
  • Other dosage forms.

By administration route:

Oral.

  • Injectable.
  • Topical.
  • Advanced drug delivery.

By end user:

  • Pharmaceutical companies.
  • Contract formulators.
  • Research institutes.
  • Other end users.

For each area, for the base year of 2023, BCC Research identified the current products in the market as well as market drivers; measured the current market size; quantified current company market shares; and made forecasts for 2029.

Report Includes

  • 73 data tables and 33 additional tables
  • An overview of the global market for excipients in pharmaceuticals industry
  • Analysis of global market trends, featuring historical revenue data from 2021 to 2023, estimated figures for 2024, and projected CAGRs through 2029
  • Evaluation of the current market's size and revenue growth prospects, along with a market share analysis by material, product type, dosage form, route of administration, end user and region
  • A look at the innovations, technological advances, clinical trials, and recent product launches
  • Analysis of the industry's regulatory framework and policies
  • A discussion of ESG challenges and ESG practices in the industry
  • An analysis of the key companies' market shares, proprietary technologies, strategic alliances and patents
  • Profiles of the leading players, including ADM, BASF SE, Roquette Freres, Ashland Global, and Croda International Plc.

Table of Contents

Chapter 1 Executive Summary

  • Market Outlook
  • Scope of Report
  • Market Summary

Chapter 2 Market Overview

  • Role of Excipients in Pharmaceuticals
  • Functions of Excipients

Chapter 3 Market Dynamics

  • Market Dynamics Snapshot
  • Market Drivers
  • Increasing Pharmaceutical and Biopharmaceutical Consumption
  • Increasing Demand for Functional Excipients
  • Increasing Demand for Novel Excipients
  • Instant Sourcing of Excipients
  • Market Restraints
  • High Development Costs
  • Lack of Independent Regulatory Body for Novel Excipients
  • Stringent Pharmaceutical Regulations
  • Market Opportunities
  • Growing Demand for Biologics, Biosimilars and Specialty Drugs
  • Market Challenges
  • Supply Chain Disruptions

Chapter 4 Emerging Technologies and Developments

  • Overview
  • 3D Printing in Drug Formulations
  • AI in Excipient Selection
  • Novel Excipients
  • Clinical Trials
  • Selected Trials

Chapter 5 Global Market for Pharmaceutical Excipients

  • Segmentation Breakdown
  • Market Breakdown by Material Type
  • Organic Excipients Market, by Type
  • Market for Inorganic Excipients, by Type
  • Market for USP Water, by Type
  • Market Breakdown by Dosage Form
  • Market Breakdown by Route of Administration
  • Market Breakdown by End User
  • Geographic Breakdown
  • Market Breakdown by Region
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Rest of the World
  • Market Breakdown by Product
  • Regional and Country-level Markets for Organic Excipients
  • Regional and Country-level Markets for Inorganic Excipients

Chapter 6 Competitive Intelligence

  • Industry Scenario
  • Company Shares
  • Competitive Landscape

Chapter 7 Sustainability in the Market for Pharmaceutical Excipients: An ESG Perspective

  • Introduction to ESG
  • Environmental Performance
  • Social Performance
  • Governance Performance
  • Concluding Remarks from BCC

Chapter 8 Appendix

  • Research Methodology
  • Abbreviations
  • References
  • Company Profiles
  • ADM
  • ASAHI KASEI CORP.
  • ASHLAND
  • BASF SE
  • CRODA INTERNATIONAL PLC
  • EVONIK INDUSTRIES AG
  • INGREDION
  • KERRY GROUP PLC
  • ROQUETTE FRERES
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦